# Poster Session II - A263 INTESTINAL EPITHELIAL CELL-SPECIFIC DELETION OF JAK2 DISRUPTS GUT HOMEOSTASIS AND INCREASES INTESTINAL PERMEABILITY

**Authors:** B D’Mello, D Rivera, S Rehal, E Pollock-Tahiri, D Dodington, K Wagner, C Streutker, M Woo

PMC · DOI: 10.1093/jcag/gwaf042.262 · Journal of the Canadian Association of Gastroenterology · 2026-02-13

## TL;DR

Deleting JAK2 in intestinal cells disrupts gut health and increases permeability, suggesting JAK inhibitors might worsen gut issues in inflammatory bowel disease.

## Contribution

This study reveals the specific role of JAK2 in maintaining intestinal barrier integrity and regulating immune genes in mice.

## Key findings

- IEC-specific Jak2 knockout mice showed increased intestinal permeability and reduced tight junction gene expression.
- vJak2 KO mice exhibited elevated Il13 and Il17, reduced Il1b and Il6, and mild inflammation in the small intestine.
- DSS-induced colitis was exacerbated in vJak2 KO mice, indicating a role for JAK2 in colitis susceptibility.

## Abstract

The intestinal epithelium is essential for barrier integrity and mucosal immune regulation. While Janus kinase (JAK)–STAT signaling is implicated in inflammatory bowel disease (IBD) and JAK inhibitors are increasingly used, the endogenous role of JAK2 in intestinal epithelial cells (IECs) remains poorly defined.

To define the in vivo role of epithelial JAK2 in barrier function, immune regulation, and colitis susceptibility.

IEC-specific Jak2 knockout (vJak2 KO) mice were generated using the Villin-Cre/loxP system. Barrier function was assessed by FITC-dextran permeability assay. Tight junction, cytokine, and cell cycle gene expression was measured by RT-PCR. Histopathology and neutrophil infiltration were evaluated in H&E-stained sections. Colitis susceptibility was tested using dextran sodium sulfate (DSS). Western blotting for total and phosphorylated STAT was performed with small intestine (SI) lysates.

vJak2 KO mice were born at expected ratios and maintained normal body weight. When examined at 12 weeks of age, they had developed shortened colons and mild SI inflammation. vJak2 KO mice showed increased intestinal permeability, reduced tight junction gene expression, elevated Il13 and Il17, and reduced Il1b and Il6. Histology revealed neutrophil infiltration, villous blunting, and higher pathology scores in the SI without overt colitis. In a model of DSS-induced colitis, vJak2 KO mice exhibited modest, and dose-dependent exacerbation of weight loss. Western blot analysis of SI lysates revealed largely preserved pSTAT1/tSTAT1, pSTAT3/tSTAT3, and pSTAT5/tSTAT5, with a selective increase in pSTAT6/tSTAT6 in vJak2 KO mice.

Epithelial Jak2 supports barrier integrity and regulates expression of genes involved in mucosal immune state and integrity under steady-state conditions. These findings indicate that broad JAK inhibition may compromise epithelial function in IBD, highlighting the need to clarify the specific roles of JAKs and STATs in gut homeostasis and disease towards optimal therapeutic targeting.

CIHR

## Linked entities

- **Genes:** JAK2 (Janus kinase 2) [NCBI Gene 3717], IL13 (interleukin 13) [NCBI Gene 3596], IL17A (interleukin 17A) [NCBI Gene 3605], IL1B (interleukin 1 beta) [NCBI Gene 3553], IL6 (interleukin 6) [NCBI Gene 3569], STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772], STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774], STAT5A (signal transducer and activator of transcription 5A) [NCBI Gene 6776], STAT6 (signal transducer and activator of transcription 6) [NCBI Gene 6778]
- **Proteins:** JAK2 (Janus kinase 2), SOAT1 (sterol O-acyltransferase 1)
- **Diseases:** inflammatory bowel disease (MONDO:0005265), colitis (MONDO:0005292)
- **Species:** Mus musculus (taxon 10090)

---
Source: https://tomesphere.com/paper/PMC12900843